Anavex Life Sciences Corp (AVXL)

[McMagyar]

Anavex hires Ariana, next Interview:

No Benefits to Dual Therapy! Logically you would think this a negative!
When we put them together we receive no greater benefit..

NO GREATER BENEFIT over ????????? the drugs used separately?
NO GREATER BENEFIT over..say it with me each drug as Mono-Therapy!
That makes sense...
Since we KNOW that our A2-73 has shown Efficacy so far with Dual Therapy, and that efficacy, not including HAM-D Positives, appears to at least equal Donezipil mono therapy, than is the good Dr. trying to
cough out that A2-73 in Mono Therapy is BETTER than Dual Therapy and MonoTherapy with Donexpipil?

The good Dr can not say ..Mono Therapy with A2-73 is better than Dual Therapy, or better than DZP. Because A2-73 Phase 2a is about SAFETY and A2-73 showing Efficacy, not measuring it.
So the good Dr could not say, we appear to have the new SOC, and it appears to work better without DZP, but really,
Is that NOT what the good Dr. JUST DID?

Ariana is going to help us clarify what we have and what we don't. We don't have a drug that plays better with Donezipil Type Drugs(Memantine, etc..).
What we have is a drug that plays really well with the Sigma 1 Ligand, a Homeostasis Chaperone located in EVERY MAJOR ORGAN throughout the body..
Heart, Mind, Eyes, Diabetes, CNS, Depression, etc..
Ladies and gentleman..Biogen is one lucky Company..
It will not take Biogen long to figure this out..
Not long at all..